0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and India Peptic Ulcer Drugs Market Report & Forecast 2023-2029
Published Date: November 2023
|
Report Code: QYRE-Auto-7H16217
Home | Market Reports | Health| Health Conditions
Global and India Peptic Ulcer Drugs Market Report Forecast 2023 2029
BUY CHAPTERS

Global and India Peptic Ulcer Drugs Market Report & Forecast 2023-2029

Code: QYRE-Auto-7H16217
Report
November 2023
Pages:104
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

and India Peptic Ulcer Drugs Market Size

The global Peptic Ulcer Drugs revenue was US$ 17470 million in 2022 and is forecast to a readjusted size of US$ 22750 million by 2029 with a CAGR of 3.8% during the forecast period (2023-2029).

and India Peptic Ulcer Drugs Market

and India Peptic Ulcer Drugs Market

A peptic ulcer is a round or oval sore where the lining of the stomach or duodenum has been eaten away by stomach acid and digestive juices. Peptic ulcers can result from Helicobacter pylori infection or from drugs that weaken the lining of the stomach or duodenum. This report mainly studies Peptic Ulcer Drugs market.
In India, the Peptic Ulcer Drugs revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2023-2029).
The main global Peptic Ulcer Drugs players include Takeda Pharmaceutical, AstraZeneca, Pfizer, Teva Pharmaceuticals, EA Pharma, etc. The top five Peptic Ulcer Drugs players account for approximately 43% of the total market. United States is the largest consumer market for Peptic Ulcer Drugs, accounting for about 30%, followed by Europe and China. In terms of type, Proton Pump Inhibitors is the largest segment, with a share over 68%. And in terms of application, the largest application is Hospital and Clinic, followed by Drugstore.
This report focuses on global and India Peptic Ulcer Drugs market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Peptic Ulcer Drugs will continue to grow rapidly in the future.
Global Peptic Ulcer Drugs Scope and Market Size
Peptic Ulcer Drugs market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Peptic Ulcer Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2029.
For India market, this report focuses on the Peptic Ulcer Drugs market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Scope of and India Peptic Ulcer Drugs Market Report

Report Metric Details
Report Name and India Peptic Ulcer Drugs Market
Forecasted market size in 2029 US$ 22750 million
CAGR 3.8%
Forecasted years 2023 - 2029
Segment by Type
  • Proton Pump Inhibitors
  • H2-Antagonists
  • Antacids
  • Others
Segment by Application
  • Hospital and Clinic
  • Drugstore
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Takeda Pharmaceutical, AstraZeneca, Pfizer, Teva Pharmaceuticals, EA Pharma, ASK Pharm, Luoxin Pharmaceutical, Abbott Laboratories, Yuhan Pharmaceutical, Daewoong Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

What is the and India Peptic Ulcer Drugs Market size in 2029?

Ans: The and India Peptic Ulcer Drugs Market size in 2029 will be US$ 22750 million.

What is the market share of major companies in and India Peptic Ulcer Drugs Market?

Ans: The top five Peptic Ulcer Drugs players account for approximately 43% of the total market.

What is the and India Peptic Ulcer Drugs Market share by region?

Ans: United States is the largest consumer market for Peptic Ulcer Drugs, accounting for about 30%, followed by Europe and China. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment.

What is the and India Peptic Ulcer Drugs Market share by type?

Ans: In terms of type, Proton Pump Inhibitors is the largest segment, with a share over 68%.

Who are the main players in the and India Peptic Ulcer Drugs Market report?

Ans: The main players in the and India Peptic Ulcer Drugs Market are Takeda Pharmaceutical, AstraZeneca, Pfizer, Teva Pharmaceuticals, EA Pharma, ASK Pharm, Luoxin Pharmaceutical, Abbott Laboratories, Yuhan Pharmaceutical, Daewoong Pharmaceutical

What are the Application segmentation covered in the and India Peptic Ulcer Drugs Market report?

Ans: The Applications covered in the and India Peptic Ulcer Drugs Market report are Hospital and Clinic, Drugstore

What are the Type segmentation covered in the and India Peptic Ulcer Drugs Market report?

Ans: The Types covered in the and India Peptic Ulcer Drugs Market report are Proton Pump Inhibitors, H2-Antagonists, Antacids, Others

1 Study Coverage
1.1 Peptic Ulcer Drugs Product Introduction
1.2 Global Peptic Ulcer Drugs Outlook 2018 VS 2022 VS 2029
1.2.1 Global Peptic Ulcer Drugs Sales in US$ Million for the Year 2018-2029
1.2.2 Global Peptic Ulcer Drugs Sales in Volume for the Year 2018-2029
1.3 India Peptic Ulcer Drugs Outlook 2018 VS 2022 VS 2029
1.3.1 India Peptic Ulcer Drugs Sales in US$ Million for the Year 2018-2029
1.3.2 India Peptic Ulcer Drugs Sales in Volume for the Year 2018-2029
1.4 Peptic Ulcer Drugs Market Size, India VS Global, 2018 VS 2022 VS 2029
1.4.1 The Market Share of India Peptic Ulcer Drugs in Global, 2018 VS 2022 VS 2029
1.4.2 The Growth Rate of Peptic Ulcer Drugs Market Size, India VS Global, 2018 VS 2022 VS 2029
1.5 Peptic Ulcer Drugs Market Dynamics
1.5.1 Peptic Ulcer Drugs Industry Trends
1.5.2 Peptic Ulcer Drugs Market Drivers
1.5.3 Peptic Ulcer Drugs Market Challenges
1.5.4 Peptic Ulcer Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Peptic Ulcer Drugs by Type
2.1 Peptic Ulcer Drugs Market Segment by Type
2.1.1 Proton Pump Inhibitors
2.1.2 H2-Antagonists
2.1.3 Antacids
2.1.4 Others
2.2 Global Peptic Ulcer Drugs Market Size by Type
2.2.1 Global Peptic Ulcer Drugs Sales in Value, by Type (2018, 2022 & 2029)
2.2.2 Global Peptic Ulcer Drugs Sales in Volume, by Type (2018, 2022 & 2029)
2.2.3 Global Peptic Ulcer Drugs Average Selling Price (ASP) by Type (2018, 2022 & 2029)
2.3 India Peptic Ulcer Drugs Market Size by Type
2.3.1 India Peptic Ulcer Drugs Sales in Value, by Type (2018, 2022 & 2029)
2.3.2 India Peptic Ulcer Drugs Sales in Volume, by Type (2018, 2022 & 2029)
2.3.3 India Peptic Ulcer Drugs Average Selling Price (ASP) by Type (2018, 2022 & 2029)
3 Peptic Ulcer Drugs by Application
3.1 Peptic Ulcer Drugs Market Segment by Application
3.1.1 Hospital and Clinic
3.1.2 Drugstore
3.2 Global Peptic Ulcer Drugs Market Size by Application
3.2.1 Global Peptic Ulcer Drugs Sales in Value, by Application (2018, 2022 & 2029)
3.2.2 Global Peptic Ulcer Drugs Sales in Volume, by Application (2018, 2022 & 2029)
3.3.3 Global Peptic Ulcer Drugs Average Selling Price (ASP) by Application (2018, 2022 & 2029)
3.3 India Peptic Ulcer Drugs Market Size by Application
3.3.1 India Peptic Ulcer Drugs Sales in Value, by Application (2018, 2022 & 2029)
3.3.2 India Peptic Ulcer Drugs Sales in Volume, by Application (2018, 2022 & 2029)
3.3.3 India Peptic Ulcer Drugs Average Selling Price (ASP) by Application (2018, 2022 & 2029)
4 Global Peptic Ulcer Drugs Competitor Landscape by Company
4.1 Global Peptic Ulcer Drugs Market Size by Company
4.1.1 Global Key Manufacturers of Peptic Ulcer Drugs, Ranked by Revenue (2022)
4.1.2 Global Peptic Ulcer Drugs Revenue by Manufacturer (2018-2023)
4.1.3 Global Peptic Ulcer Drugs Sales by Manufacturer (2018-2023)
4.1.4 Global Peptic Ulcer Drugs Price by Manufacturer (2018-2023)
4.2 Global Peptic Ulcer Drugs Concentration Ratio (CR)
4.2.1 Peptic Ulcer Drugs Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Peptic Ulcer Drugs in 2022
4.2.3 Global Peptic Ulcer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Peptic Ulcer Drugs, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Peptic Ulcer Drugs, Product Offered and Application
4.5 Global Key Manufacturers of Peptic Ulcer Drugs, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 India Peptic Ulcer Drugs Market Size by Company
4.7.1 Key Players of Peptic Ulcer Drugs in India, Ranked by Revenue (2022)
4.7.2 India Peptic Ulcer Drugs Revenue by Players (2018-2023)
4.7.3 India Peptic Ulcer Drugs Sales by Players (2018-2023)
5 Global Peptic Ulcer Drugs Market Size by Region
5.1 Global Peptic Ulcer Drugs Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Peptic Ulcer Drugs Market Size in Volume by Region (2018-2029)
5.2.1 Global Peptic Ulcer Drugs Sales in Volume by Region: 2018-2023
5.2.2 Global Peptic Ulcer Drugs Sales in Volume Forecast by Region (2024-2029)
5.3 Global Peptic Ulcer Drugs Market Size in Value by Region (2018-2029)
5.3.1 Global Peptic Ulcer Drugs Sales in Value by Region: 2018-2023
5.3.2 Global Peptic Ulcer Drugs Sales in Value by Region: 2024-2029
6 Americas
6.1 Americas Peptic Ulcer Drugs Market Size YoY Growth 2018-2029
6.2 Americas Peptic Ulcer Drugs Sales in Volume, by Type (2018, 2022 & 2029)
6.3 Americas Peptic Ulcer Drugs Sales in Volume, by Application (2018, 2022 & 2029)
6.4 Americas Peptic Ulcer Drugs Market Facts & Figures by Country (2018, 2022 & 2029)
6.4.1 Americas Peptic Ulcer Drugs Sales in Value by Country (2018, 2022 & 2029)
6.4.2 Americas Peptic Ulcer Drugs Sales in Volume by Country (2018, 2022 & 2029)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Peptic Ulcer Drugs Market Size YoY Growth 2018-2029
7.2 EMEA Peptic Ulcer Drugs Sales in Volume, by Type (2018, 2022 & 2029)
7.3 EMEA Peptic Ulcer Drugs Sales in Volume, by Application (2018, 2022 & 2029)
7.4 EMEA Peptic Ulcer Drugs Market Facts & Figures by Country (2018, 2022 & 2029)
7.4.1 EMEA Peptic Ulcer Drugs Sales in Value by Country (2018, 2022 & 2029)
7.4.2 EMEA Peptic Ulcer Drugs Sales in Volume by Country (2018, 2022 & 2029)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Peptic Ulcer Drugs Market Size YoY Growth 2018-2029
8.2 China Peptic Ulcer Drugs Sales in Volume, by Type (2018, 2022 & 2029)
8.3 China Peptic Ulcer Drugs Sales in Volume, by Application (2018, 2022 & 2029)
9 APAC
9.1 APAC Peptic Ulcer Drugs Market Size YoY Growth 2018-2029
9.2 APAC Peptic Ulcer Drugs Sales in Volume, by Type (2018, 2022 & 2029)
9.3 APAC Peptic Ulcer Drugs Sales in Volume, by Application (2018, 2022 & 2029)
9.4 APAC Peptic Ulcer Drugs Market Facts & Figures by Region (2018, 2022 & 2029)
9.4.1 APAC Peptic Ulcer Drugs Sales in Value by Region (2018, 2022 & 2029)
9.4.2 APAC Peptic Ulcer Drugs Sales in Volume by Region (2018, 2022 & 2029)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Takeda Pharmaceutical
10.1.1 Takeda Pharmaceutical Company Information
10.1.2 Takeda Pharmaceutical Description and Business Overview
10.1.3 Takeda Pharmaceutical Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Takeda Pharmaceutical Peptic Ulcer Drugs Products Offered
10.1.5 Takeda Pharmaceutical Recent Development
10.2 AstraZeneca
10.2.1 AstraZeneca Company Information
10.2.2 AstraZeneca Description and Business Overview
10.2.3 AstraZeneca Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 AstraZeneca Peptic Ulcer Drugs Products Offered
10.2.5 AstraZeneca Recent Development
10.3 Pfizer
10.3.1 Pfizer Company Information
10.3.2 Pfizer Description and Business Overview
10.3.3 Pfizer Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Pfizer Peptic Ulcer Drugs Products Offered
10.3.5 Pfizer Recent Development
10.4 Teva Pharmaceuticals
10.4.1 Teva Pharmaceuticals Company Information
10.4.2 Teva Pharmaceuticals Description and Business Overview
10.4.3 Teva Pharmaceuticals Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Teva Pharmaceuticals Peptic Ulcer Drugs Products Offered
10.4.5 Teva Pharmaceuticals Recent Development
10.5 EA Pharma
10.5.1 EA Pharma Company Information
10.5.2 EA Pharma Description and Business Overview
10.5.3 EA Pharma Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 EA Pharma Peptic Ulcer Drugs Products Offered
10.5.5 EA Pharma Recent Development
10.6 ASK Pharm
10.6.1 ASK Pharm Company Information
10.6.2 ASK Pharm Description and Business Overview
10.6.3 ASK Pharm Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2018-2023)
10.6.4 ASK Pharm Peptic Ulcer Drugs Products Offered
10.6.5 ASK Pharm Recent Development
10.7 Luoxin Pharmaceutical
10.7.1 Luoxin Pharmaceutical Company Information
10.7.2 Luoxin Pharmaceutical Description and Business Overview
10.7.3 Luoxin Pharmaceutical Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Luoxin Pharmaceutical Peptic Ulcer Drugs Products Offered
10.7.5 Luoxin Pharmaceutical Recent Development
10.8 Abbott Laboratories
10.8.1 Abbott Laboratories Company Information
10.8.2 Abbott Laboratories Description and Business Overview
10.8.3 Abbott Laboratories Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Abbott Laboratories Peptic Ulcer Drugs Products Offered
10.8.5 Abbott Laboratories Recent Development
10.9 Yuhan Pharmaceutical
10.9.1 Yuhan Pharmaceutical Company Information
10.9.2 Yuhan Pharmaceutical Description and Business Overview
10.9.3 Yuhan Pharmaceutical Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Yuhan Pharmaceutical Peptic Ulcer Drugs Products Offered
10.9.5 Yuhan Pharmaceutical Recent Development
10.10 Daewoong Pharmaceutical
10.10.1 Daewoong Pharmaceutical Company Information
10.10.2 Daewoong Pharmaceutical Description and Business Overview
10.10.3 Daewoong Pharmaceutical Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Daewoong Pharmaceutical Peptic Ulcer Drugs Products Offered
10.10.5 Daewoong Pharmaceutical Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Peptic Ulcer Drugs Industry Chain Analysis
11.2 Peptic Ulcer Drugs Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Peptic Ulcer Drugs Production Mode & Process
11.4 Peptic Ulcer Drugs Sales and Marketing
11.4.1 Peptic Ulcer Drugs Sales Channels
11.4.2 Peptic Ulcer Drugs Distributors
11.5 Peptic Ulcer Drugs Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
    Table 1. Peptic Ulcer Drugs CAGR in Value, India VS Global, 2018 VS 2022 VS 2029
    Table 2. Peptic Ulcer Drugs Market Trends
    Table 3. Peptic Ulcer Drugs Market Drivers
    Table 4. Peptic Ulcer Drugs Market Challenges
    Table 5. Peptic Ulcer Drugs Market Restraints
    Table 6. Global Peptic Ulcer Drugs Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 7. India Peptic Ulcer Drugs Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 8. Global Peptic Ulcer Drugs Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 9. India Peptic Ulcer Drugs Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 10. Global Key Manufacturers of Peptic Ulcer Drugs, Ranked by Revenue (2022) & (US$ Million)
    Table 11. Global Peptic Ulcer Drugs Revenue by Manufacturer, (US$ Million), 2018-2023
    Table 12. Global Peptic Ulcer Drugs Revenue Share by Manufacturer, 2018-2023
    Table 13. Global Peptic Ulcer Drugs Sales by Manufacturer, (M Unit), 2018-2023
    Table 14. Global Peptic Ulcer Drugs Sales Share by Manufacturer, 2018-2023
    Table 15. Global Peptic Ulcer Drugs Price by Manufacturer (2018-2023) & (USD/K Units)
    Table 16. Global Peptic Ulcer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Peptic Ulcer Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptic Ulcer Drugs as of 2022)
    Table 18. Global Key Manufacturers of Peptic Ulcer Drugs, Manufacturing Base Distribution and Headquarters
    Table 19. Global Key Manufacturers of Peptic Ulcer Drugs, Product Offered and Application
    Table 20. Global Key Manufacturers of Peptic Ulcer Drugs, Date of Enter into This Industry
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Key Players of Peptic Ulcer Drugs in India, Ranked by Revenue (2022) & (US$ million)
    Table 23. India Peptic Ulcer Drugs Revenue by Players, (US$ Million), (2018-2023)
    Table 24. India Peptic Ulcer Drugs Revenue Share by Players, (2018-2023)
    Table 25. India Peptic Ulcer Drugs Sales by Players, (M Unit), (2018-2023)
    Table 26. India Peptic Ulcer Drugs Sales Share by Players, (2018-2023)
    Table 27. Global Peptic Ulcer Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 28. Global Peptic Ulcer Drugs Sales in Volume by Region (2018-2023) & (M Unit)
    Table 29. Global Peptic Ulcer Drugs Sales in Volume Forecast by Region (2024-2029) & (M Unit)
    Table 30. Global Peptic Ulcer Drugs Sales in Value by Region (2018-2023) & (US$ Million)
    Table 31. Global Peptic Ulcer Drugs Sales in Value Forecast by Region (2024-2029) & (US$ Million)
    Table 32. Americas Peptic Ulcer Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 33. Americas Peptic Ulcer Drugs Sales in Value by Country (2018-2023) & (US$ Million)
    Table 34. Americas Peptic Ulcer Drugs Sales in Value by Country (2024-2029) & (US$ Million)
    Table 35. Americas Peptic Ulcer Drugs Sales in Volume by Country (2018-2023) & (M Unit)
    Table 36. Americas Peptic Ulcer Drugs Sales in Volume by Country (2024-2029) & (M Unit)
    Table 37. EMEA Peptic Ulcer Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 38. EMEA Peptic Ulcer Drugs Sales in Value by Country (2018-2023) & (US$ Million)
    Table 39. EMEA Peptic Ulcer Drugs Sales in Value by Country (2024-2029) & (US$ Million)
    Table 40. EMEA Peptic Ulcer Drugs Sales in Volume by Country (2018-2023) & (M Unit)
    Table 41. EMEA Peptic Ulcer Drugs Sales in Volume by Country (2024-2029) & (M Unit)
    Table 42. APAC Peptic Ulcer Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 43. APAC Peptic Ulcer Drugs Sales in Value by Country (2018-2023) & (US$ Million)
    Table 44. APAC Peptic Ulcer Drugs Sales in Value by Country (2024-2029) & (US$ Million)
    Table 45. APAC Peptic Ulcer Drugs Sales in Volume by Country (2018-2023) & (M Unit)
    Table 46. APAC Peptic Ulcer Drugs Sales in Volume by Country (2024-2029) & (M Unit)
    Table 47. Takeda Pharmaceutical Company Information
    Table 48. Takeda Pharmaceutical Description and Business Overview
    Table 49. Takeda Pharmaceutical Peptic Ulcer Drugs Sales (M Unit), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2018-2023)
    Table 50. Takeda Pharmaceutical Peptic Ulcer Drugs Product
    Table 51. Takeda Pharmaceutical Recent Development
    Table 52. AstraZeneca Company Information
    Table 53. AstraZeneca Description and Business Overview
    Table 54. AstraZeneca Peptic Ulcer Drugs Sales (M Unit), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2018-2023)
    Table 55. AstraZeneca Peptic Ulcer Drugs Product
    Table 56. AstraZeneca Recent Development
    Table 57. Pfizer Company Information
    Table 58. Pfizer Description and Business Overview
    Table 59. Pfizer Peptic Ulcer Drugs Sales (M Unit), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2018-2023)
    Table 60. Pfizer Peptic Ulcer Drugs Product
    Table 61. Pfizer Recent Development
    Table 62. Teva Pharmaceuticals Company Information
    Table 63. Teva Pharmaceuticals Description and Business Overview
    Table 64. Teva Pharmaceuticals Peptic Ulcer Drugs Sales (M Unit), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2018-2023)
    Table 65. Teva Pharmaceuticals Peptic Ulcer Drugs Product
    Table 66. Teva Pharmaceuticals Recent Development
    Table 67. EA Pharma Company Information
    Table 68. EA Pharma Description and Business Overview
    Table 69. EA Pharma Peptic Ulcer Drugs Sales (M Unit), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2018-2023)
    Table 70. EA Pharma Peptic Ulcer Drugs Product
    Table 71. EA Pharma Recent Development
    Table 72. ASK Pharm Company Information
    Table 73. ASK Pharm Description and Business Overview
    Table 74. ASK Pharm Peptic Ulcer Drugs Sales (M Unit), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2018-2023)
    Table 75. ASK Pharm Peptic Ulcer Drugs Product
    Table 76. ASK Pharm Recent Development
    Table 77. Luoxin Pharmaceutical Company Information
    Table 78. Luoxin Pharmaceutical Description and Business Overview
    Table 79. Luoxin Pharmaceutical Peptic Ulcer Drugs Sales (M Unit), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2018-2023)
    Table 80. Luoxin Pharmaceutical Peptic Ulcer Drugs Product
    Table 81. Luoxin Pharmaceutical Recent Development
    Table 82. Abbott Laboratories Company Information
    Table 83. Abbott Laboratories Description and Business Overview
    Table 84. Abbott Laboratories Peptic Ulcer Drugs Sales (M Unit), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2018-2023)
    Table 85. Abbott Laboratories Peptic Ulcer Drugs Product
    Table 86. Abbott Laboratories Recent Development
    Table 87. Yuhan Pharmaceutical Company Information
    Table 88. Yuhan Pharmaceutical Description and Business Overview
    Table 89. Yuhan Pharmaceutical Peptic Ulcer Drugs Sales (M Unit), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2018-2023)
    Table 90. Yuhan Pharmaceutical Peptic Ulcer Drugs Product
    Table 91. Yuhan Pharmaceutical Recent Development
    Table 92. Daewoong Pharmaceutical Company Information
    Table 93. Daewoong Pharmaceutical Description and Business Overview
    Table 94. Daewoong Pharmaceutical Peptic Ulcer Drugs Sales (M Unit), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2018-2023)
    Table 95. Daewoong Pharmaceutical Peptic Ulcer Drugs Product
    Table 96. Daewoong Pharmaceutical Recent Development
    Table 97. Key Raw Materials Lists
    Table 98. Raw Materials Key Suppliers Lists
    Table 99. Peptic Ulcer Drugs Customers List
    Table 100. Peptic Ulcer Drugs Distributors List
    Table 101. Research Programs/Design for This Report
    Table 102. Key Data Information from Secondary Sources
    Table 103. Key Data Information from Primary Sources
List of Figures
    Figure 1. Peptic Ulcer Drugs Product Picture
    Figure 2. Global Peptic Ulcer Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Peptic Ulcer Drugs Market Size 2018-2029 (US$ Million)
    Figure 4. Global Peptic Ulcer Drugs Sales 2018-2029 (M Unit)
    Figure 5. India Peptic Ulcer Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 6. India Peptic Ulcer Drugs Market Size 2018-2029 (US$ Million)
    Figure 7. India Peptic Ulcer Drugs Sales 2018-2029 (M Unit)
    Figure 8. India Peptic Ulcer Drugs Market Share in Global, in Value (US$ Million) 2018-2029
    Figure 9. India Peptic Ulcer Drugs Market Share in Global, in Volume (M Unit) 2018-2029
    Figure 10. Peptic Ulcer Drugs Report Years Considered
    Figure 11. Product Picture of Proton Pump Inhibitors
    Figure 12. Product Picture of H2-Antagonists
    Figure 13. Product Picture of Antacids
    Figure 14. Product Picture of Others
    Figure 15. Global Peptic Ulcer Drugs Market Share by Type in 2022 & 2029
    Figure 16. Global Peptic Ulcer Drugs Sales in Value by Type (2018-2029) & (US$ Million)
    Figure 17. Global Peptic Ulcer Drugs Sales Market Share in Value by Type (2018-2029)
    Figure 18. Global Peptic Ulcer Drugs Sales by Type (2018-2029) & (M Unit)
    Figure 19. Global Peptic Ulcer Drugs Sales Market Share in Volume by Type (2018-2029)
    Figure 20. Global Peptic Ulcer Drugs Price by Type (2018-2029) & (USD/K Units)
    Figure 21. India Peptic Ulcer Drugs Market Share by Type in 2022 & 2029
    Figure 22. India Peptic Ulcer Drugs Sales in Value by Type (2018-2029) & (US$ Million)
    Figure 23. India Peptic Ulcer Drugs Sales Market Share in Value by Type (2018-2029)
    Figure 24. India Peptic Ulcer Drugs Sales by Type (2018-2029) & (M Unit)
    Figure 25. India Peptic Ulcer Drugs Sales Market Share in Volume by Type (2018-2029)
    Figure 26. India Peptic Ulcer Drugs Price by Type (2018-2029) & (USD/K Units)
    Figure 27. Product Picture of Hospital and Clinic
    Figure 28. Product Picture of Drugstore
    Figure 29. Global Peptic Ulcer Drugs Market Share by Application in 2022 & 2029
    Figure 30. Global Peptic Ulcer Drugs Sales in Value by Application (2018-2029) & (US$ Million)
    Figure 31. Global Peptic Ulcer Drugs Sales Market Share in Value by Application (2018-2029)
    Figure 32. Global Peptic Ulcer Drugs Sales by Application (2018-2029) & (M Unit)
    Figure 33. Global Peptic Ulcer Drugs Sales Market Share in Volume by Application (2018-2029)
    Figure 34. Global Peptic Ulcer Drugs Price by Application (2018-2029) & (USD/K Units)
    Figure 35. India Peptic Ulcer Drugs Market Share by Application in 2022 & 2029
    Figure 36. India Peptic Ulcer Drugs Sales in Value by Application (2018-2029) & (US$ Million)
    Figure 37. India Peptic Ulcer Drugs Sales Market Share in Value by Application (2018-2029)
    Figure 38. India Peptic Ulcer Drugs Sales by Application (2018-2029) & (M Unit)
    Figure 39. India Peptic Ulcer Drugs Sales Market Share in Volume by Application (2018-2029)
    Figure 40. India Peptic Ulcer Drugs Price by Application (2018-2029) & (USD/K Units)
    Figure 41. Americas Peptic Ulcer Drugs Sales in Volume Growth Rate 2018-2029 (M Unit)
    Figure 42. Americas Peptic Ulcer Drugs Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 43. Americas Peptic Ulcer Drugs Sales by Type (2018-2029) & (M Unit)
    Figure 44. Americas Peptic Ulcer Drugs Sales Market Share in Volume by Type (2018-2029)
    Figure 45. Americas Peptic Ulcer Drugs Sales by Application (2018-2029) & (M Unit)
    Figure 46. Americas Peptic Ulcer Drugs Sales Market Share in Volume by Application (2018-2029)
    Figure 47. United States Peptic Ulcer Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 48. Canada Peptic Ulcer Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 49. Mexico Peptic Ulcer Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 50. Brazil Peptic Ulcer Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 51. EMEA Peptic Ulcer Drugs Sales in Volume Growth Rate 2018-2029 (M Unit)
    Figure 52. EMEA Peptic Ulcer Drugs Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 53. EMEA Peptic Ulcer Drugs Sales by Type (2018-2029) & (M Unit)
    Figure 54. EMEA Peptic Ulcer Drugs Sales Market Share in Volume by Type (2018-2029)
    Figure 55. EMEA Peptic Ulcer Drugs Sales by Application (2018-2029) & (M Unit)
    Figure 56. EMEA Peptic Ulcer Drugs Sales Market Share in Volume by Application (2018-2029)
    Figure 57. Europe Peptic Ulcer Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 58. Middle East Peptic Ulcer Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 59. Africa Peptic Ulcer Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 60. China Peptic Ulcer Drugs Sales in Volume Growth Rate 2018-2029 (M Unit)
    Figure 61. China Peptic Ulcer Drugs Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 62. China Peptic Ulcer Drugs Sales by Type (2018-2029) & (M Unit)
    Figure 63. China Peptic Ulcer Drugs Sales Market Share in Volume by Type (2018-2029)
    Figure 64. China Peptic Ulcer Drugs Sales by Application (2018-2029) & (M Unit)
    Figure 65. China Peptic Ulcer Drugs Sales Market Share in Volume by Application (2018-2029)
    Figure 66. APAC Peptic Ulcer Drugs Sales in Volume Growth Rate 2018-2029 (M Unit)
    Figure 67. APAC Peptic Ulcer Drugs Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 68. APAC Peptic Ulcer Drugs Sales by Type (2018-2029) & (M Unit)
    Figure 69. APAC Peptic Ulcer Drugs Sales Market Share in Volume by Type (2018-2029)
    Figure 70. APAC Peptic Ulcer Drugs Sales by Application (2018-2029) & (M Unit)
    Figure 71. APAC Peptic Ulcer Drugs Sales Market Share in Volume by Application (2018-2029)
    Figure 72. Japan Peptic Ulcer Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 73. South Korea Peptic Ulcer Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 74. China Taiwan Peptic Ulcer Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 75. Southeast Asia Peptic Ulcer Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 76. India Peptic Ulcer Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 77. Peptic Ulcer Drugs Value Chain
    Figure 78. Peptic Ulcer Drugs Production Process
    Figure 79. Channels of Distribution
    Figure 80. Distributors Profiles
    Figure 81. Bottom-up and Top-down Approaches for This Report
    Figure 82. Data Triangulation
    Figure 83. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4350

This license allows only one user to access the PDF.
Electronic (PDF)

$6525

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$8700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Coronary Imaging Catheter Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32P14840
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Digital Platform for Chronic Kidney Disease (CKD) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20V18395
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Continuous Glucose Monitoring Sensor Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32G20014
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Radioactive Iodine Ablation Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9U20281
Tue Dec 02 00:00:00 UTC 2025

Add to Cart